![[Tebubio Newsletter - Edition 5] Pink October: Standing Together for Research](https://www.tebubio.com/media/magefan_blog/Posts_2025/Newsletter_Banner_1500x300px_1_.png)
Welcome to the Fifth Edition Of The Tebubio Newsletter
Every October, the pink ribbon reminds us that the fight against cancer is a shared responsibility. At Tebubio, we are deeply committed to supporting the scientists who, day after day, push the boundaries of knowledge and open new therapeutic horizons.
By providing a wide range of reagents and research solutions, we aim to be more than a supplier; we strive to be a trusted partner for those working to understand, prevent, and treat cancer. Every discovery matters, and we are proud to play our part in this collective effort.
Upcoming Event
Join our Case Study Webinar
Register to attend our webinar and explore how mRNA is shaping the future of therapeutics.
Dr Erica Cirri and Dr Xavier Warnet will guide you through the essential steps of mRNA design and production, the creation of a 3D colorectal cancer model, and the encapsulation of mRNA in lipid nanoparticles (LNPs) for effective delivery.
Speakers: Erica Cirri, PhD & Xavier Warnet, PhD
Date: Thursday, October 16th | 10:00 AM CEST
Product Highlight
New Dye From Spirochrome: HAK-Actin
Actin dynamics are central to countless biological processes, and now you can visualise them with unmatched precision. HAK-Actin, the latest fluorescent probe from our partner Spirochrome, offers researchers a powerful new way to track actin in living cells.
Discover this innovative tool now available through Tebubio.
Product Highlight
CleanCap IVT Kits for mRNA Synthesis
mRNA therapeutics and vaccines demand high yield and high fidelity. CleanCap IVT Kits are engineered to deliver both, enabling efficient in vitro transcription with clean capping and minimal by-products.
Discover how these kits can elevate your mRNA workflows.
Oncology
CJ15, Next-Generation Animal Imaging Dye
See tumours with unmatched clarity. CJ215 delivers high-contrast NIR/SWIR fluorescence, binds specifically to tumour tissue and remains stable in vivo for up to 168 hours, enabling extended imaging sessions.
Validated across breast, pancreatic, prostate, colon and fibrosarcoma models, CJ215 integrates seamlessly into pre-clinical oncology workflows.
Immunology
Pertussis Toxin: Proven Tool for Reliable Disease Models
Build confidence in your pre-clinical research with List Labs Pertussis Toxin (PTX), trusted worldwide for more than 40 years.
-
Gold-standard performance: Widely used to induce EAE in mice, the benchmark model for multiple sclerosis and autoimmunity.
-
Versatile: Ideal for exploring Gi/o-coupled receptor pathways.
-
Flexible formats: Choose frozen in glycerol or lyophilised, with or without salts, to match your workflow.
Oncology
Thunder™ TR-FRET Kits: High-Performance Assays Without the Premium Price
Looking for sensitivity, flexibility, and speed in your assays?
Thunder™ TR-FRET Kits are designed to deliver high-performance screening results with a straightforward workflow, making them an excellent fit for drug discovery and target validation studies. See how they can boost the efficiency of your research.
Oncology
SLC Transporter Studies Without Delays: TransiPORT Cells, the Proven Alternative
Studying solute carrier (SLC) transporters doesn’t need to be complicated. With TransiPORT cells, you get a reliable, ready-to-use cellular system that eliminates the hassle of setting up your own models while ensuring reproducible results.
Explore how these cells can accelerate and simplify your transporter research.
Tebubio Contract Research Services
Tebubio in Pharma's Almanac
How is precision medicine reshaping cancer treatment, and what does this mean for developers?
Our expert Erica Cirri, PhD, contributed to Pharma’s Almanac in a roundtable discussion exploring these critical questions. Don’t miss her insights on how innovation and collaboration are driving new opportunities in oncology.
Knowledge Resources
 |
 |
 |
| Research Domain Page: Download all Tebubio Brochures and Flyers | Video: |
Article: Lysosomes at the Crossroads of Health and Disease: Solutions for In-Depth Functional Studies |
New Partnership
New Partner Spotlight: ProMab Biotechnologies
We’re excited to introduce ProMab Biotechnologies, our newest partner providing advanced research tools to accelerate immunotherapy, vaccine, and gene therapy projects. With nearly 20 years of expertise, ProMab is committed to supporting researchers with highly specific monoclonal antibodies, CAR-T & CAR-NK development, and mRNA-LNP gene delivery platforms.
ProMab’s comprehensive tools are designed to help you move from concept to reliable experimental data faster.
Monthly Highlight
Tebubio Partners with Eurobiomed for Greater Patient Impact
Tebubio is proud to join forces with Eurobiomed, the leading healthtech cluster in Southern France.
By combining Tebubio’s expertise with Eurobiomed’s dynamic network, we aim to foster collaboration, accelerate scientific advances, and support impactful projects that make a real difference for patients and society.
Building A Sustainable Future Together
A Workplace for People & Planet
We’ve reopened our French offices near Paris, redesigned with sustainability, well-being, and collaboration at heart.
From eco-conscious design to ergonomic workstations and creative spaces, they offer a welcoming and collaborative environment for our teams, partners and customers to innovate together.
Stay Ahead in Your Research
Subscribe to our monthly newsletter for the latest breakthroughs, expert insights, and exclusive updates in key research areas.